AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 29278449 — intervention group
Group type: EXPERIMENTAL
Intervention: Retraining of volunteers in food production techniques and nutrition behaviour change counselling
Number of subjects: 0
Study 29278449 — intervention group
Group type: EXPERIMENTAL
Intervention: Addition of small incentives for volunteers
Number of subjects: 0
Study 29278449 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaboration with International Food Policy Research Institute
Number of subjects: 0
Study 26796500 — intervention group
Group type: EXPERIMENTAL
Intervention: Early Complete Remitters (ECRs) after 4 ECT sessions
Number of subjects: 87
Study 26796500 — intervention group
Group type: COMPARATOR
Intervention: Late Complete Remitters (LCRs) after 9 to 12 ECT sessions
Number of subjects: 87
Study 26796500 — intervention group
Group type: EXPERIMENTAL
Intervention: ECRs
Number of subjects: 87
Study 25030722 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin and nonsteroidal anti-inflammatory drug combination therapy
Number of subjects: 0
Study 25030722 — intervention group
Group type: COMPARATOR
Intervention: Nonsteroidal anti-inflammatory drug monotherapy
Number of subjects: 0
Study 23165739 — intervention group
Group type: EXPERIMENTAL
Intervention: 5‐HT (50 µg)
Number of subjects: 25
Study 23165739 — intervention group
Group type: COMPARATOR
Intervention: Histamine (0.2 µg)
Number of subjects: 25
Study 23165739 — intervention group
Group type: COMPARATOR
Intervention: Buffer
Number of subjects: 25
Study 20801896 — intervention group
Group type: EXPERIMENTAL
Intervention: PROP
Number of subjects: 48
Study 20801896 — intervention group
Group type: COMPARATOR
Intervention: NaCl
Number of subjects: 48
Study 18473097 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftriaxone
Number of subjects: 107
Study 18473097 — intervention group
Group type: COMPARATOR
Intervention: Trimethoprim-sulfamethoxazole (SXT)
Number of subjects: 107
Study 15845675 — intervention group
Group type: EXPERIMENTAL
Intervention: Parecoxib 40 mg
Number of subjects: 182
Study 15845675 — intervention group
Group type: COMPARATOR
Intervention: Propacetamol 2 g
Number of subjects: 182
Study 12875586 — intervention group
Group type: EXPERIMENTAL
Intervention: Warm water immersion of feet at 42 degrees C
Number of subjects: 0
Study 12875586 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal lidocaine
Number of subjects: 0
Study 12875586 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenoxybenzamine (alpha-sympathetic blocking agent) applied to nasal mucosa
Number of subjects: 0
Study 12875586 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetylcholine
Number of subjects: 0
Study 10442799 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine (20 mg, n = 184)
Number of subjects: 375
Study 10442799 — intervention group
Group type: COMPARATOR
Intervention: Amitriptyline (50-100 mg, n = 191)
Number of subjects: 375
Study 7790289 — intervention group
Group type: EXPERIMENTAL
Intervention: Program H (high intensity and variety of stimuli)
Number of subjects: 20
Study 7790289 — intervention group
Group type: EXPERIMENTAL
Intervention: Program HL (transient from high to low)
Number of subjects: 20
Study 7790289 — intervention group
Group type: COMPARATOR
Intervention: Program L (low stimulation)
Number of subjects: 20
Study 7790289 — intervention group
Group type: EXPERIMENTAL
Intervention: All programs
Number of subjects: 20
Study 2185977 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% ethanolamine oleate
Number of subjects: 90
Study 2185977 — intervention group
Group type: EXPERIMENTAL
Intervention: 3% sodium tetradecyl sulfate
Number of subjects: 90
Study 2185977 — intervention group
Group type: EXPERIMENTAL
Intervention: Absolute alcohol
Number of subjects: 90
Study 467482 — intervention group
Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate (ISDN), 5 mg, sublingually
Number of subjects: 5
Study 467482 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine (N), 10 mg, orally
Number of subjects: 5
Study 467482 — intervention group
Group type: EXPERIMENTAL
Intervention: Verapamil (V), 160 mg, orally
Number of subjects: 5
Study 467482 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (Pr), 40 mg, orally
Number of subjects: 5
Study 467482 — intervention group
Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 5
Study 31268224 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided Self‐Determination‐Young (GSD‐Y) intervention, 7 group training sessions over 5 months
Number of subjects: 71
Study 31268224 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided Self‐Determination‐Young (GSD‐Y) intervention
Number of subjects: 71
Study 31268224 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 71
Study 26675352 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone Power program (theory-based online bone health program)
Number of subjects: 866
Study 26675352 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 866
Study 25843674 — intervention group
Group type: EXPERIMENTAL
Intervention: Lotrafilcon B (Air Optix(®)AQUA)
Number of subjects: 60
Study 25843674 — intervention group
Group type: COMPARATOR
Intervention: Balafilcon A (PureVision™)
Number of subjects: 60
Study 23497630 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone counseling delivered by VA staff
Number of subjects: 0
Study 23497630 — intervention group
Group type: COMPARATOR
Intervention: Telephone counseling delivered by state quitlines
Number of subjects: 0
Study 21871667 — intervention group
Group type: EXPERIMENTAL
Intervention: Solution-Focused Therapy (SFT)
Number of subjects: 326
Study 21871667 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-Term Psychodynamic Psychotherapy (SPP)
Number of subjects: 326
Study 21871667 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-Term Psychodynamic Psychotherapy (LPP)
Number of subjects: 326
Study 21871667 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychoanalysis (PA)
Number of subjects: 326
Study 21871667 — intervention group
Group type: COMPARATOR
Intervention: Short-Term Therapy
Number of subjects: 326
Study 19356391 — intervention group
Group type: EXPERIMENTAL
Intervention: Eslicarbazepine acetate (ESL) 1200 mg once daily for 6 days
Number of subjects: 20
Study 19356391 — intervention group
Group type: COMPARATOR
Intervention: Metformin hydrochloride 850 mg single-dose
Number of subjects: 20
Study 18193500 — intervention group
Group type: EXPERIMENTAL
Intervention: Poly-L-lactic acid (PLA) injections administered every 2 weeks for 4 treatments
Number of subjects: 101
Study 18193500 — intervention group
Group type: COMPARATOR
Intervention: Control group (deferred PLA treatment)
Number of subjects: 101
Study 15043527 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital 50 degrees red‐free imaging
Number of subjects: 70
Study 15043527 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-field 50 degrees colour imaging
Number of subjects: 70
Study 15043527 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-field 45 degrees colour imaging
Number of subjects: 70
Study 15043527 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand-held digital colour videocamera (MediTell)
Number of subjects: 70
Study 11136493 — intervention group
Group type: EXPERIMENTAL
Intervention: ICD therapy
Number of subjects: 1009
Study 9747746 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous IL-2 (9 Mio I.U. per day)
Number of subjects: 20
Study 9747746 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous IL-2 (9 Mio I.U. per day)
Number of subjects: 20
Study 9747746 — intervention group
Group type: COMPARATOR
Intervention: Both groups (Intravenous and Subcutaneous IL-2)
Number of subjects: 20
Study 8878381 — intervention group
Group type: EXPERIMENTAL
Intervention: FK506 (low trough level 5-14 ng/ml)
Number of subjects: 120
Study 8878381 — intervention group
Group type: EXPERIMENTAL
Intervention: FK506 (medium trough level 15-25 ng/ml)
Number of subjects: 120
Study 8878381 — intervention group
Group type: EXPERIMENTAL
Intervention: FK506 (high trough level 26-40 ng/ml)
Number of subjects: 120
Study 8878381 — intervention group
Group type: EXPERIMENTAL
Intervention: Aggregate of all FK506-treated patients
Number of subjects: 120
Study 8878381 — intervention group
Group type: COMPARATOR
Intervention: Cyclosporine
Number of subjects: 120
Study 8878381 — intervention group
Group type: EXPERIMENTAL
Intervention: FK506 (all concentrations)
Number of subjects: 120
Study 8878381 — intervention group
Group type: EXPERIMENTAL
Intervention: FK506 (increasing maximum trough concentrations)
Number of subjects: 120
Study 8878381 — intervention group
Group type: EXPERIMENTAL
Intervention: FK506 (decreasing minimum trough concentrations)
Number of subjects: 120
Study 2265113 — intervention group
Group type: EXPERIMENTAL
Intervention: hM-CSF (2 x 10(5) units/kg daily from day 1 to day 14 after BMT)
Number of subjects: 119
Study 2265113 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 119
Study 6985681 — intervention group
Group type: EXPERIMENTAL
Intervention: Subsalicylate bismuth
Number of subjects: 128
Study 6985681 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 128
Study 31920296 — intervention group
Group type: EXPERIMENTAL
Intervention: BGF MDI 320/18/9.6 μg
Number of subjects: 416
Study 31920296 — intervention group
Group type: EXPERIMENTAL
Intervention: GFF MDI 18/9.6 μg
Number of subjects: 416
Study 31920296 — intervention group
Group type: EXPERIMENTAL
Intervention: BFF MDI 320/9.6 μg
Number of subjects: 416
Study 31920296 — intervention group
Group type: EXPERIMENTAL
Intervention: BUD/FORM DPI 400/12 μg
Number of subjects: 416
Study 28635557 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard subunit TIV
Number of subjects: 120
Study 28635557 — intervention group
Group type: EXPERIMENTAL
Intervention: MF59-adjuvanted subunit TIV
Number of subjects: 120
Study 28635557 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard split-virus TIV
Number of subjects: 120
Study 28635557 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradermal split-virus TIV
Number of subjects: 120
Study 28635557 — intervention group
Group type: EXPERIMENTAL
Intervention: All vaccines
Number of subjects: 120
Study 25668581 — intervention group
Group type: EXPERIMENTAL
Intervention: Erhuangfang (treatment group, n=50)
Number of subjects: 67
Study 25668581 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=43)
Number of subjects: 67
Study 24373547 — intervention group
Group type: EXPERIMENTAL
Intervention: Filtered sunlight phototherapy (FS-PT)
Number of subjects: 616
Study 24373547 — intervention group
Group type: COMPARATOR
Intervention: Conventional phototherapy (CPT)
Number of subjects: 616
Study 20126269 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-lasting insecticidal nets (LN) distributed cluster-wide
Number of subjects: 120
Study 20126269 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 120
Study 18023995 — intervention group
Group type: EXPERIMENTAL
Intervention: Formoterol
Number of subjects: 0
Study 16651569 — intervention group
Group type: EXPERIMENTAL
Intervention: Periarticular intraoperative injection containing ropivacaine, ketorolac, epimorphine, and epinephrine
Number of subjects: 64
Study 16651569 — intervention group
Group type: COMPARATOR
Intervention: No injection (Control)
Number of subjects: 64
Study 14645314 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulmonary artery catheter (PAC)
Number of subjects: 676
Study 10967001 — intervention group
Group type: EXPERIMENTAL
Intervention: Danazol
Number of subjects: 0
Study 10967001 — intervention group
Group type: EXPERIMENTAL
Intervention: Medroxyprogesterone acetate
Number of subjects: 0
Study 10967001 — intervention group
Group type: EXPERIMENTAL
Intervention: Nafarelin
Number of subjects: 0
Study 10967001 — intervention group
Group type: COMPARATOR
Intervention: No pre-treatment (Control)
Number of subjects: 0
Study 8949810 — intervention group
Group type: EXPERIMENTAL
Intervention: Droperidol added to morphine infusion
Number of subjects: 398
Study 8949810 — intervention group
Group type: COMPARATOR
Intervention: Control group (no droperidol)
Number of subjects: 398
Study 2023758 — intervention group
Group type: EXPERIMENTAL
Intervention: Keeping eyelids closed for 2 minutes after drop placement
Number of subjects: 12
Study 2023758 — intervention group
Group type: EXPERIMENTAL
Intervention: Keeping eyelids closed for 2 to 5 minutes after drop placement
Number of subjects: 12
Study 6784982 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-acting analogue of met-enkephalin (DAMME)
Number of subjects: 0
Study 6784982 — intervention group
Group type: EXPERIMENTAL
Intervention: Naloxone
Number of subjects: 0
Study 6784982 — intervention group
Group type: EXPERIMENTAL
Intervention: Naloxone (long-term infusion)
Number of subjects: 0
Study 6784982 — intervention group
Group type: COMPARATOR
Intervention: High-dose DAMME infusion
Number of subjects: 0
Study 31419294 — intervention group
Group type: EXPERIMENTAL
Intervention: PfSPZ Challenge (7G8) with 8x102 PfSPZ
Number of subjects: 0
Study 31419294 — intervention group
Group type: EXPERIMENTAL
Intervention: PfSPZ Challenge (7G8) with 4.8x103 PfSPZ
Number of subjects: 0
Study 28903864 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone furoate and vilanterol (100 μg or 200 μg with 25 μg vilanterol)
Number of subjects: 4233
Study 28903864 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone furoate and vilanterol
Number of subjects: 4233
Study 28903864 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 4233
Study 25857703 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition education intervention (four sessions of group trainings and cooking demonstrations over 5 months)
Number of subjects: 20
Study 25857703 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition education intervention
Number of subjects: 20
Study 23122512 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational program consisting of four educational sessions on epilepsy, including a self-management plan.
Number of subjects: 60
Study 23122512 — intervention group
Group type: COMPARATOR
Intervention: Control group (no educational program).
Number of subjects: 60
Study 21724195 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublobar resection with brachytherapy (SRB)
Number of subjects: 224
Study 21724195 — intervention group
Group type: COMPARATOR
Intervention: Sublobar resection alone (SR)
Number of subjects: 224
Study 21724195 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower-lobe tumors
Number of subjects: 224
Study 21724195 — intervention group
Group type: EXPERIMENTAL
Intervention: Upper-lobe tumors
Number of subjects: 224
Study 19410392 — intervention group
Group type: EXPERIMENTAL
Intervention: DHEA 50mg daily
Number of subjects: 93
Study 19410392 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 93
Study 17493402 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with CAN
Number of subjects: 18
Study 17493402 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients without CAN
Number of subjects: 18
Study 17493402 — intervention group
Group type: COMPARATOR
Intervention: Healthy control group
Number of subjects: 18
Study 15068141 — intervention group
Group type: EXPERIMENTAL
Intervention: Tissue Harmonic Imaging (THI)
Number of subjects: 20
Study 15068141 — intervention group
Group type: COMPARATOR
Intervention: Fundamental Imaging (FI)
Number of subjects: 20
Study 15068141 — intervention group
Group type: COMPARATOR
Intervention: Comparison with MRI
Number of subjects: 20
Study 15068141 — intervention group
Group type: EXPERIMENTAL
Intervention: Inter-observer variability
Number of subjects: 20
Study 11803660 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone grafts with hard tissue replacement synthetic bone
Number of subjects: 18
Study 11803660 — intervention group
Group type: COMPARATOR
Intervention: Untreated sockets (control)
Number of subjects: 18
Study 9508013 — intervention group
Group type: EXPERIMENTAL
Intervention: Milk diet (360 mL)
Number of subjects: 21
Study 9508013 — intervention group
Group type: COMPARATOR
Intervention: Juice diet (540 mL)
Number of subjects: 21
Study 8001541 — intervention group
Group type: EXPERIMENTAL
Intervention: Creatine supplementation (4 x 5 g.day‐1 for 5 days)
Number of subjects: 0
Study 8001541 — intervention group
Group type: COMPARATOR
Intervention: Placebo ingestion
Number of subjects: 0
Study 8001541 — intervention group
Group type: EXPERIMENTAL
Intervention: Creatine supplementation
Number of subjects: 0
Study 2969930 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine 10 mg/day
Number of subjects: 16
Study 2969930 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 2969930 — intervention group
Group type: COMPARATOR
Intervention: Single blind placebo
Number of subjects: 16
Study 29637845 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training
Number of subjects: 145
Study 29637845 — intervention group
Group type: EXPERIMENTAL
Intervention: Circuit only weekly performances
Number of subjects: 145
Study 29637845 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 145
Study 28486426 — intervention group
Group type: EXPERIMENTAL
Intervention: Low GI diet (isomaltulose, PalatinoseTM)
Number of subjects: 20
Study 28486426 — intervention group
Group type: COMPARATOR
Intervention: High GI diet (sucrose)
Number of subjects: 20
Study 25531413 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrauterine injection of 500 IU hCG before embryo transfer
Number of subjects: 483
Study 25531413 — intervention group
Group type: COMPARATOR
Intervention: Placebo (tissue culture media) before embryo transfer
Number of subjects: 483
Study 24060300 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal injection of 4 mg of triamcinolone acetonide (TA) plus grid laser photocoagulation (GLP)
Number of subjects: 30
Study 24060300 — intervention group
Group type: COMPARATOR
Intervention: Grid laser photocoagulation (GLP)
Number of subjects: 30
Study 21340561 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal steroids
Number of subjects: 0
Study 21340561 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal surgery
Number of subjects: 0
Study 21340561 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal airway surgery
Number of subjects: 0
Study 21340561 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 18445106 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol high concentration (breathalyzer = 0.100 g/dl)
Number of subjects: 60
Study 18445106 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol low concentration (breathalyzer = 0.040 g/dl)
Number of subjects: 60
Study 18445106 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 18445106 — intervention group
Group type: COMPARATOR
Intervention: Comparison of FHP to FHN subjects
Number of subjects: 60
Study 16784923 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin (10 mg/day)
Number of subjects: 10
Study 16784923 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 15058045 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A (progressive workload)
Number of subjects: 42
Study 15058045 — intervention group
Group type: EXPERIMENTAL
Intervention: Group B (interval training)
Number of subjects: 42
Study 15058045 — intervention group
Group type: COMPARATOR
Intervention: Group C (no training)
Number of subjects: 42
Study 11020003 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon alpha2b plus ribavirin (1000 mg/day)
Number of subjects: 60
Study 11020003 — intervention group
Group type: COMPARATOR
Intervention: Double dosage of alpha‐interferon (6 million units tiw)
Number of subjects: 60
Study 11020003 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon alpha2b (3 million units 3 times a week)
Number of subjects: 60
Study 9093599 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous infusion of anti-TNF alpha Fab, 30 min before penicillin in 20 patients
Number of subjects: 49
Study 9093599 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 29)
Number of subjects: 49
Study 8179545 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine 2‐stage examination (early dating and 34‐week scan)
Number of subjects: 1528
Study 8179545 — intervention group
Group type: COMPARATOR
Intervention: Only a dating scan and additional scans as generated by clinical situations
Number of subjects: 1528
Study 3153213 — intervention group
Group type: EXPERIMENTAL
Intervention: Regimen A (five different drug associations including VM26 and IDMTX in a sequential schedule)
Number of subjects: 102
Study 3153213 — intervention group
Group type: EXPERIMENTAL
Intervention: Regimen B (classical Spiers schedule for the first year, followed by milder treatment)
Number of subjects: 102
Study 3153213 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients relapsing after 12 months from suspension of treatment in first complete remission
Number of subjects: 102
Study 3153213 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients relapsing within the first year off therapy
Number of subjects: 102
Study 3153213 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A (Regimen A)
Number of subjects: 102
Study 30209050 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose folic acid (4.0 mg/day, four 1.0 mg oral tablets) from 8 weeks of gestation to week 16 until delivery.
Number of subjects: 2464
Study 30209050 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group).
Number of subjects: 2464
Study 26495961 — intervention group
Group type: EXPERIMENTAL
Intervention: Abatacept
Number of subjects: 0
Study 26495961 — intervention group
Group type: COMPARATOR
Intervention: Adalimumab
Number of subjects: 0
Study 24494804 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyanoacrylate
Number of subjects: 45
Study 24494804 — intervention group
Group type: COMPARATOR
Intervention: Conventional technique
Number of subjects: 45
Study 24494804 — intervention group
Group type: COMPARATOR
Intervention: Microsurgery
Number of subjects: 45
Study 22520140 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral pentavalent rotavirus vaccine (PRV), RotaTeq, 3 doses at approximately 6, 10, and 14 weeks of age
Number of subjects: 1960
Study 22520140 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral pentavalent rotavirus vaccine (PRV), RotaTeq
Number of subjects: 1960
Study 22520140 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1960
Study 20118150 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple group (cilostazol 100 mg twice daily + clopidogrel 75 mg daily)
Number of subjects: 90
Study 20118150 — intervention group
Group type: EXPERIMENTAL
Intervention: High maintenance dose (MD) group (clopidogrel 150 mg daily)
Number of subjects: 90
Study 20118150 — intervention group
Group type: COMPARATOR
Intervention: Standard group (clopidogrel 75 mg daily)
Number of subjects: 90